Discriminative and distinct phenoty** by constrained tensor factorization

Y Kim, R El-Kareh, J Sun, H Yu, X Jiang - Scientific reports, 2017 - nature.com
Abstract Adoption of Electronic Health Record (EHR) systems has led to collection of
massive healthcare data, which creates oppor-tunities and challenges to study them …

Modeling strategies to analyse longitudinal biomarker data: An illustration on predicting immunotherapy non-response in non-small cell lung cancer

FA van Delft, M Schuurbiers, M Muller, SA Burgers… - Heliyon, 2022 - cell.com
Serum tumor markers acquired through a blood draw are known to reflect tumor activity.
Their non-invasive nature allows for more frequent testing compared to traditional imaging …

Rapidly decreasing level of prostate-specific antigen during initial androgen deprivation therapy is a risk factor for early progression to castration-resistant prostate …

G Ji, G Song, C Huang, S He, L Zhou - Medicine, 2017 - journals.lww.com
Rapidly decreasing level of prostate-specific antigen during... : Medicine Rapidly decreasing
level of prostate-specific antigen during initial androgen deprivation therapy is a risk factor for …

A simple prognostic model involving prostate-specific antigen, alkaline phosphatase and albumin for predicting the time required to progress to castration-resistant …

W Lv, H Shang, X Pei, Y Chen, H **e, D He… - … urology and nephrology, 2017 - Springer
Purpose To distinguish potential biomarkers and build a useful model to predict the time
required to progress to castration-resistant prostate cancer (CRPC) in patients with prostate …

Genistein resists castration-resistant prostate cancer by inhibiting the androgen receptor pathway

XP Yu, LJ Zheng, JL Yan, Y Luo, XL Song… - Journal of Asian …, 2025 - Taylor & Francis
Prostate cancer is a prevalent malignancy, often diagnosed at advanced stages and
associated with poor prognosis. Genistein, a soybean isoflavone, has demonstrated …

Simple risk assessment in prostate cancer patients treated with primary androgen deprivation therapy: The Korean Cancer Study of the Prostate risk classification

SY Choi, J Ryu, D You, JH Hong… - International Journal of …, 2019 - Wiley Online Library
Objectives To investigate the progression to castration‐resistant prostate cancer after
primary androgen deprivation therapy, and to build a simple risk prediction model for …

Prostate cancer in omics era

N Gholami, A Haghparast, I Alipourfard… - Cancer Cell …, 2022 - Springer
Recent advances in omics technology have prompted extraordinary attempts to define the
molecular changes underlying the onset and progression of a variety of complex human …

[HTML][HTML] 前列腺癌骨转移进展为去势抵抗的预测因素分析

谭信韬, 黄卓韦, 刘秋礼, 彭松, 黄义**, 唐堂, 江军 - 2021 - aammt.tmmu.edu.cn
目的探讨前列腺癌骨转移进展为去势抵抗的预测因素, 建立风险预测模型. 方法收集2010 年1
月至2020 年7 月在本院泌尿外科确诊为前列腺癌伴骨转移, 初始治疗为内分泌治疗 …

DTMBIO 2011: international workshop on data and textmining in biomedical informatics

S Ananiadou, D Lee, S Navathe, M Song - Proceedings of the 20th ACM …, 2011 - dl.acm.org
ACM Fifth International Workshop on Data and Text Mining in Biomedical Informatics
(DTMBIO 11) organizers are pleased to announce that the fifth DTMBIO will be held in …